A Randomised Clinical Investigation to Assess Efficacy of Low Volume Transanal Irrigation by Qufora® IrriSedo MiniGo Versus Conservative Treatment for Low Anterior Resection Syndrome Patients

This study is testing a small, low-volume bowel irrigation device (Qufora IrriSedo MiniGo) versus standard conservative treatment for people who have Low Anterior Resection Syndrome (LARS) after rectal cancer surgery. LARS causes bowel problems like urgency, leakage, and frequent trips to the toilet. **You may be eligible if...** - You are 18 or older - You had rectal cancer treated with low anterior resection surgery (colon reconnected, not a permanent stoma) - It has been 3 to 18 months since your surgery or stoma reversal - Your LARS symptoms are significant (score ≥ 25 on the LARS scale) - You have already tried at least 1 month of conservative treatments (diet, medications, etc.) - You are physically and mentally capable of operating the device yourself **You may NOT be eligible if...** - There are signs of anastomotic leakage or significant narrowing at the surgical site - Your rectal cancer has come back - You have had a permanent stoma Talk to your doctor to see if this trial is right for you.